https://www.gosh.nhs.uk/news/gosh-statement-new-personalised-therapy-children-cancer/
GOSH statement on new personalised therapy for children with cancer
5 Sep 2018, 3:56 p.m.
Professor Persis Amrolia, Consultant in Bone Marrow Transplant at Great Ormond Street Hospital (GOSH), says:
“GOSH welcomes the exciting announcement that for children with Acute Lymphoblastic Leukaemia (ALL), CAR-T cell therapy will be made available on the NHS.
“This is a landmark moment in the treatment of childhood cancer in the UK. GOSH has been at the forefront of cutting edge personalised CAR-T therapy treatment for a number of years developing similar CAR-T therapies for children with ALL. Since 2012, we have treated over 25 patients from all over the UK with CAR-T therapies. In 2015, we treated the first patient worldwide with gene edited “universal” CAR-T cells. We are continuing to work on improving CAR-T cell therapy including using “next generation” CAR-T cells to further reduce the chance of relapse.
“We believe that personalised cell therapy treatments, which allow us to tailor treatments to individual patients, can be the silver bullet, offering a real chance of success for children who have run out of all other options.”
Professor Amrolia is also a NIHR Research Professor of Transplantation Immunology at UCL Great Ormond Street Institute of Child Health.
Working together to transform research
Our Highlight Report shines a spotlight on some of our brightest and best work in 2025-26. Our Impact report brings together a series of case studies and reflections that showcase the breadth and depth of PPIE across our organisation.
UK-wide excellence in paediatrics
Through the Paediatric Excellence Initiative, the NIHR GOSH Biomedical Research Centre is building a connected, collaborative UK-wide system to accelerate paediatric research.
Families and researchers come together for BPAN Family Day
Families affected by BPAN came together with clinicians and researchers at GOSH
Professor Helen Cross elected to the Academy of Medical Sciences
Professor Helen Cross, Paediatric Neurology Consultant at GOSH and Director of the UCL Great Ormond Street Institute of Child Health, has been elected to the prestigious Academy of Medical Sciences.